Barrett's oESophagus trial 3 (BEST3): study protocol for a randomised controlled trial comparing the Cytosponge-TFF3 test with usual care to facilitate the diagnosis of oesophageal pre-cancer in primary care patients with chronic acid reflux

Offman, J; Muldrew, B; O'Donovan, M; Debiram-Beecham, I; Pesola, F; Kaimi, I; Smith, SG; ... BEST3 Trial team, .; + view all Offman, J; Muldrew, B; O'Donovan, M; Debiram-Beecham, I; Pesola, F; Kaimi, I; Smith, SG; Wilson, A; Khan, Z; Lao-Sirieix, P; Aigret, B; Walter, FM; Rubin, G; Morris, S; Jackson, C; Sasieni, P; Fitzgerald, RC; BEST3 Trial team, .; - view fewer (2018) Barrett's oESophagus trial 3 (BEST3): study protocol for a randomised controlled trial comparing the Cytosponge-TFF3 test with usual care to facilitate the diagnosis of oesophageal pre-cancer in primary care patients with chronic acid reflux. BMC Cancer , 18 , Article 784. 10.1186/s12885-018-4664-3 . Green open access

https://ift.tt/2Q1WQLs